Catalent Inc (CTLT) Stock News
NYSE:CTLT - New York Stock Exchange, Inc. - US1488061029 - Common Stock - Currency: USD
CTLT Latest News, Press Relases and Analysis
Catalent Announces New Board Appointments
Lennox To Join S&P 500 Index, Replacing Catalent
Lennox, an AI cooling play, will join the S&P 500 before the open on Dec. 23. Bill Holdings will take its pace in the S&P Midcap 400.
Lennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400
/PRNewswire/ -- S&P MidCap 400 constituent Lennox International Inc. (NYSE: LII) will replace Catalent Inc. (NYSE: CTLT) in the S&P 500, and BILL Holdings Inc....
Novo Holdings Completes Acquisition of Catalent
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
Novo Nordisk unveils a $1.2 billion production facility in Denmark and finalizes Catalent acquisition, with financial and operational impacts ahead.
Mentions: NVO
Novo Nordisk Set to Close Catalent Deal Without FTC Challenge
Novo Nordisk A/S can advance with its acquisition of factories from contract development and manufacturing organization Catalent Inc. after the Federal Trade Commission declined to challenge the deal.
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction
Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction
Novo Wins EU Approval for Deal to Acquire Catalent Plants
Novo Holdings, the shareholder that controls Novo Nordisk A/S, won European Union approval for its acquisition of Catalent Inc.
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity.
Catalent, Inc. Reports First Quarter Fiscal 2025 Results
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the Catalent acquisition.
Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
Sodexo Buying Aramark Would Buck Trend of US Deals in Europe
A potential $10 billion acquisition of catering firm Aramark by France’s Sodexo SA would go against the typical pattern of American companies targeting European rivals.
Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
A Relative Strength Rating upgrade for Tempus AI shows improving technical performance.
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
A small telemedicine company just entered the weight loss race.
Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Eli Lilly is in a buy zone, while rival Novo Nordisk forged a lower entry.
Catalent Stockholders Approve Transaction with Novo Holdings
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, DRQ, FUSN
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...